Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Gastric Mucosal Microarchitectures Associated with Irreversibility with Helicobacter pylori Eradication and Downregulation of Micro RNA (miR)-124a.

Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Nagasaka M, Nakagawa Y, Shibata T, Urano M, Tsukamoto T, Kuroda M, Ohmiya N.

Cancer Invest. 2019 Sep 13:1-10. doi: 10.1080/07357907.2019.1663207. [Epub ahead of print]

PMID:
31483161
2.

Prostate Stem Cell Antigen Gene Polymorphism Is Associated with H. pylori-related Promoter DNA Methylation in Nonneoplastic Gastric Epithelium.

Tahara T, Tahara S, Horiguchi N, Kato T, Shinkai Y, Okubo M, Terada T, Yoshida D, Funasaka K, Nagasaka M, Nakagawa Y, Kurahashi H, Shibata T, Tsukamoto T, Ohmiya N.

Cancer Prev Res (Phila). 2019 Sep;12(9):579-584. doi: 10.1158/1940-6207.CAPR-19-0035. Epub 2019 Jun 18.

PMID:
31213476
3.

Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.

Sato K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Andou M, Matsuda Y, Uraoka T, Ohnishi H, Okamoto H.

World J Clin Cases. 2019 May 6;7(9):1043-1052. doi: 10.12998/wjcc.v7.i9.1043.

4.

Eradication of Helicobacter pylori Induces Immediate Regressive Changes in Early Gastric Adenocarcinomas.

Nakagawa M, Sakai Y, Kiriyama Y, Tahara T, Horiguchi N, Okabe A, Tahara S, Shibata T, Ohmiya N, Kuroda M, Sugioka A, Tsukamoto T.

Pathobiology. 2019;86(2-3):135-144. doi: 10.1159/000496692. Epub 2019 Mar 15.

PMID:
30879008
5.

Pharmacokinetic-Pharmacodynamic Modeling of Brain Dopamine Levels Based on Dopamine Transporter Occupancy after Administration of Methylphenidate in Rats.

Shimizu R, Horiguchi N, Yano K, Sakuramoto M, Kanegawa N, Shinohara S, Ohnishi S.

J Pharmacol Exp Ther. 2019 Apr;369(1):78-87. doi: 10.1124/jpet.118.252262. Epub 2019 Jan 23.

PMID:
30674560
6.

Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology.

Uehara D, Hayashi Y, Seki Y, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yasuda K, Yamada M, Uraoka T, Kasama K.

World J Hepatol. 2018 Dec 27;10(12):934-943. doi: 10.4254/wjh.v10.i12.934.

7.

Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.

Tahara T, Tahara S, Horiguchi N, Okubo M, Terada T, Yamada H, Yoshida D, Omori T, Osaki H, Maeda K, Kamano T, Funasaka K, Nagasaka M, Nakagawa Y, Shibata T, Ohmiya N.

Hum Mutat. 2019 Mar;40(3):347-354. doi: 10.1002/humu.23700. Epub 2019 Jan 15.

PMID:
30575210
8.

Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.

Uehara D, Seki Y, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yamada M, Uraoka T, Kasama K.

Obes Surg. 2019 Apr;29(4):1195-1201. doi: 10.1007/s11695-018-03641-2.

PMID:
30542827
9.

Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis.

Uehara D, Tojima H, Kakizaki S, Yamazaki Y, Horiguchi N, Takizawa D, Sato K, Yamada M, Uraoka T.

Dig Liver Dis. 2019 Feb;51(2):226-235. doi: 10.1016/j.dld.2018.10.008. Epub 2018 Oct 22.

PMID:
30442521
10.

Selective Role of the Putamen in Serial Reversal Learning in the Marmoset.

Jackson SAW, Horst NK, Axelsson SFA, Horiguchi N, Cockcroft GJ, Robbins TW, Roberts AC.

Cereb Cortex. 2019 Jan 1;29(1):447-460. doi: 10.1093/cercor/bhy276.

11.

DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.

Tahara S, Tahara T, Horiguchi N, Kato T, Shinkai Y, Yamashita H, Yamada H, Kawamura T, Terada T, Okubo M, Nagasaka M, Nakagawa Y, Shibata T, Yamada S, Urano M, Tsukamoto T, Kurahashi H, Kuroda M, Ohmiya N.

Int J Cancer. 2019 Jan 1;144(1):80-88. doi: 10.1002/ijc.31667. Epub 2018 Nov 12.

PMID:
29978464
12.

Unusual growth of an Epstein-Barr virus-associated differentiated early-stage gastric carcinoma: A case report.

Horiguchi N, Tahara T, Kawamura T, Okubo M, Ishizuka T, Nakano N, Nakagawa Y, Nagasaka M, Nakagawa M, Tsukamoto T, Shibata T, Ohmiya N.

Mol Clin Oncol. 2018 May;8(5):657-660. doi: 10.3892/mco.2018.1586. Epub 2018 Mar 5.

13.

Systemic administration of guanfacine improves food-motivated impulsive choice behavior primarily via direct stimulation of postsynaptic α2A-adrenergic receptors in rats.

Nishitomi K, Yano K, Kobayashi M, Jino K, Kano T, Horiguchi N, Shinohara S, Hasegawa M.

Behav Brain Res. 2018 Jun 1;345:21-29. doi: 10.1016/j.bbr.2018.02.022. Epub 2018 Feb 21.

PMID:
29476896
14.

A Comparative Study of White Light Endoscopy, Chromoendoscopy and Magnifying Endoscopy with Narrow Band Imaging in the Diagnosis of Early Gastric Cancer after Helicobacter pylori Eradication.

Horiguchi N, Tahara T, Kawamura T, Okubo M, Tahara S, Nagasaka M, Nakagawa Y, Shibata T, Ohmiya N.

J Gastrointestin Liver Dis. 2017 Dec;26(4):357-362. doi: 10.15403/jgld.2014.1121.264.hpy.

15.

Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis.

Tahara T, Hirata I, Nakano N, Tahara S, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tuskamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N.

Oncotarget. 2017 Jun 27;8(37):61917-61926. doi: 10.18632/oncotarget.18716. eCollection 2017 Sep 22.

16.

Methylation status of IGF2 DMR and LINE1 in leukocyte DNA provides distinct clinicopathological features of gastric cancer patients.

Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tsukamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N.

Clin Exp Med. 2018 May;18(2):215-220. doi: 10.1007/s10238-017-0471-4. Epub 2017 Sep 4.

PMID:
28871451
17.

Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.

Sato K, Naganuma A, Nagashima T, Hoshino T, Uehara D, Arai Y, Horiuchi K, Yuasa K, Takayama H, Arai H, Hatanaka T, Ohyama T, Tahara H, Sohara N, Kobayashi T, Horiguchi N, Yamazaki Y, Kakizaki S, Kusano M, Yamada M, Murase T, Nakamura T.

Hepatol Res. 2018 Feb;48(3):E347-E353. doi: 10.1111/hepr.12971. Epub 2017 Sep 25.

PMID:
28834004
18.

Endoscopic features of lymphoid follicles using blue laser imaging (BLI) endoscopy in the colorectum and its association with chronic bowel symptoms.

Tahara T, Takahama K, Tahara S, Yoshida D, Horiguchi N, Kawamura T, Okubo M, Nagasaka M, Nakagawa Y, Urano M, Shibata T, Tuskamoto T, Ieda HO, Kuroda M, Ohmiya N.

PLoS One. 2017 Aug 1;12(8):e0182224. doi: 10.1371/journal.pone.0182224. eCollection 2017.

19.

In vivo diagnosis of early-stage gastric cancer found after Helicobacter pylori eradication using probe-based confocal laser endomicroscopy.

Horiguchi N, Tahara T, Yamada H, Yoshida D, Okubo M, Nagasaka M, Nakagawa Y, Shibata T, Tsukamoto T, Kuroda M, Ohmiya N.

Dig Endosc. 2018 Mar;30(2):219-227. doi: 10.1111/den.12926. Epub 2017 Aug 23.

PMID:
28731617
20.

An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.

Yamazaki Y, Suzuki A, Hirayanagi K, Tsukagoshi Y, Uehara R, Horiguchi K, Ohyama T, Tomaru T, Horiguchi N, Nobusawa S, Ikota H, Sato K, Kakizaki S, Kusano M, Ikeda Y, Yokoo H, Yamada M.

Intern Med. 2017;56(14):1897-1901. doi: 10.2169/internalmedicine.56.7980. Epub 2017 Jul 15.

21.

Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk.

Tahara T, Tahara S, Tuskamoto T, Horiguchi N, Yoshida D, Kawamura T, Okubo M, Nagasaka M, Nakagawa Y, Urano M, Kuroda M, Shibata T, Ohmiya N.

Dig Dis Sci. 2017 Sep;62(9):2421-2427. doi: 10.1007/s10620-017-4676-x. Epub 2017 Jul 12.

PMID:
28702753
22.

In vivo characterization of abnormalities in small-bowel diseases using probe-based confocal laser endomicroscopy.

Ohmiya N, Horiguchi N, Tahara T, Nagasaka M, Nakagawa Y, Shibata T, Tsukamoto T, Kuroda M.

Endosc Int Open. 2017 Jul;5(7):E547-E558. doi: 10.1055/s-0043-106184. Epub 2017 Jun 23.

23.

Histological evaluations of primary lesions are independently associated with prognosis in patients with gastric cancer who receive neoadjuvant chemotherapy.

Tahara T, Shibata T, Okubo M, Yoshida D, Kawamura T, Horiguchi N, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N.

Oncol Lett. 2017 Jun;13(6):4892-4896. doi: 10.3892/ol.2017.6040. Epub 2017 Apr 18.

24.

Magnifying narrow-band imaging of gastric mucosal morphology predicts the H. pylori-related epigenetic field defect.

Tahara T, Yamazaki J, Tahara S, Okubo M, Kawamura T, Horiguchi N, Ishizuka T, Nagasaka M, Nakagawa Y, Shibata T, Kuroda M, Ohmiya N.

Sci Rep. 2017 Jun 8;7(1):3090. doi: 10.1038/s41598-017-03294-8.

25.

Morphologic characterization of residual DNA methylation in the gastric mucosa after Helicobacter pylori eradication.

Tahara S, Tahara T, Tuskamoto T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Shibata T, Kuroda M, Ohmiya N.

Cancer Med. 2017 Jul;6(7):1730-1737. doi: 10.1002/cam4.1082. Epub 2017 May 30.

26.

Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C.

Sato K, Kobayashi T, Yamazaki Y, Takakusagi S, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

Hepatol Res. 2017 Nov;47(12):1346-1353. doi: 10.1111/hepr.12905. Epub 2017 May 24.

PMID:
28422376
27.

Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.

Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tuskamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N.

Anticancer Res. 2017 Apr;37(4):1997-2001.

PMID:
28373473
28.

Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy.

Tahara T, Shibata T, Okubo M, Kawamura T, Horiguchi N, Yoshida D, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N.

PLoS One. 2017 Mar 13;12(3):e0173663. doi: 10.1371/journal.pone.0173663. eCollection 2017.

29.

Usefulness of confocal laser endomicroscopy to diagnose ulcerative colitis-associated neoplasia.

Ohmiya N, Horiguchi N, Tahara T, Yoshida D, Yamada H, Nagasaka M, Nakagawa Y, Shibata T, Tsukamoto T, Kuroda M.

Dig Endosc. 2017 Jul;29(5):626-633. doi: 10.1111/den.12853. Epub 2017 Mar 27.

PMID:
28244237
30.

Telomere length in the gastric mucosa after Helicobacter pylori eradication and its potential role in the gastric carcinogenesis.

Tahara T, Tahara S, Tuskamoto T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Shibata T, Kuroda M, Ohmiya N.

Clin Exp Med. 2018 Feb;18(1):21-26. doi: 10.1007/s10238-017-0458-1. Epub 2017 Feb 14.

PMID:
28197807
31.

Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional Study.

Sato K, Hosonuma K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Kusano M, Ohnishi H, Okamoto H, Yamada M.

Tohoku J Exp Med. 2017 Jan;241(1):45-53. doi: 10.1620/tjem.241.45.

32.

[A Case of Transfusion-transmitted Acute Hepatitis E].

Kobayashi T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M, Yokohama A, Okamoto H.

Nihon Naika Gakkai Zasshi. 2016 Nov;105(11):2215-20. Japanese. No abstract available.

PMID:
30178983
33.

A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication.

Tahara T, Shibata T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N.

PLoS One. 2016 Oct 5;11(10):e0163700. doi: 10.1371/journal.pone.0163700. eCollection 2016.

34.

Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.

Tahara T, Shibata T, Okamoto Y, Yamazaki J, Kawamura T, Horiguchi N, Okubo M, Nakano N, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N.

Oncotarget. 2016 Jul 5;7(27):42252-60. doi: 10.18632/oncotarget.9770.

35.

Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015.

Yamazaki Y, Naganuma A, Arai Y, Takeuchi S, Kobayashi T, Takakusagi S, Hatanaka T, Hoshino T, Namikawa M, Hashizume H, Takizawa D, Ohyama T, Suzuki H, Horiguchi N, Takagi H, Sato K, Kakizaki S, Kusano M, Nagashima S, Takahashi M, Okamoto H, Yamada M.

Hepatol Res. 2017 Apr;47(5):435-445. doi: 10.1111/hepr.12765. Epub 2016 Jul 27.

PMID:
27322051
36.

Demonstration of potential link between Helicobacter pylori related promoter CpG island methylation and telomere shortening in human gastric mucosa.

Tahara T, Shibata T, Okubo M, Kawamura T, Horiguchi N, Ishizuka T, Nakano N, Nagasaka M, Nakagawa Y, Ohmiya N.

Oncotarget. 2016 Jul 12;7(28):43989-43996. doi: 10.18632/oncotarget.9764.

37.

Distinct Clinic-Pathological Features of Early Differentiated-Type Gastric Cancers after Helicobacter pylori Eradication.

Horiguchi N, Tahara T, Kawamura T, Okubo M, Ishizuka T, Nakagawa Y, Nagasaka M, Shibata T, Ohmiya N.

Gastroenterol Res Pract. 2016;2016:8230815. doi: 10.1155/2016/8230815. Epub 2016 Apr 26.

38.

Telomere length shortening in gastric mucosa is a field effect associated with increased risk of gastric cancer.

Tahara T, Shibata T, Kawamura T, Horiguchi N, Okubo M, Nakano N, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N.

Virchows Arch. 2016 Jul;469(1):19-24. doi: 10.1007/s00428-016-1948-3. Epub 2016 May 12.

PMID:
27173780
39.

Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus.

Sato K, Yamazaki Y, Ohyama T, Kobayashi T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

World J Clin Cases. 2016 Mar 16;4(3):88-93. doi: 10.12998/wjcc.v4.i3.88.

40.

Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation.

Suzuki Y, Yamazaki Y, Hashizume H, Kobayashi T, Ohyama T, Horiguchi N, Sato K, Kakizaki S, Kusano M, Yamada M.

Clin J Gastroenterol. 2016 Feb;9(1):27-31. doi: 10.1007/s12328-016-0626-y. Epub 2016 Feb 10.

PMID:
26862027
41.

Malignant Peripheral Nerve Sheath Tumor of the Liver.

Kakizaki S, Horiguchi N, Otsuka T, Takizawa D, Yamazaki Y, Sato K, Ohno Y, Kusano M, Yamada M.

Intern Med. 2016;55(3):245-9. doi: 10.2169/internalmedicine.55.5456. Epub 2016 Feb 1. Review.

42.

Probe-based confocal laser endomicroscopy (pCLE) images of submucosal growth of a duodenal mucous neck cell adenoma.

Tahara T, Horiguchi N, Nagasaka M, Nakagawa Y, Tsukamoto T, Shibata T, Ohmiya N.

Endoscopy. 2016;48 Suppl 1 UCTN:E19-21. doi: 10.1055/s-0041-111031. Epub 2016 Jan 22. No abstract available.

PMID:
26800196
43.

Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

Suga T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

World J Clin Cases. 2015 Dec 16;3(12):1005-10. doi: 10.12998/wjcc.v3.i12.1005.

44.

Hepatic Angiosarcoma with Dyskeratosis Congenita.

Horiguchi N, Kakizaki S, Iizuka K, Hagiwara S, Ohyama T, Yamazaki Y, Shibusawa N, Sato K, Kusano M, Nakazato Y, Yamada M.

Intern Med. 2015;54(22):2867-72. doi: 10.2169/internalmedicine.54.5206. Epub 2015 Nov 15.

45.

Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.

Seki Y, Kakizaki S, Horiguchi N, Hashizume H, Tojima H, Yamazaki Y, Sato K, Kusano M, Yamada M, Kasama K.

J Gastroenterol. 2016 Mar;51(3):281-9. doi: 10.1007/s00535-015-1114-8. Epub 2015 Aug 28.

PMID:
26314837
46.

[Drug-induced liver injury caused by a dietary supplement (Kin-toki Shoga(®)) made from ginger].

Suzuki Y, Yamazaki Y, Hashizume H, Oyama T, Horiguchi N, Sato K, Kakizaki S, Yamada M.

Nihon Shokakibyo Gakkai Zasshi. 2015 Jan;112(1):108-14. doi: 10.11405/nisshoshi.112.108. Japanese.

PMID:
25744927
47.

A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.

Hosonuma K, Sato K, Yamazaki Y, Yanagisawa M, Hashizume H, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

Am J Gastroenterol. 2015 Mar;110(3):423-31. doi: 10.1038/ajg.2015.20. Epub 2015 Mar 3.

PMID:
25732417
48.

MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.

Ohyama T, Sato K, Yamazaki Y, Hashizume H, Horiguchi N, Kakizaki S, Mori M, Kusano M, Yamada M.

World J Gastroenterol. 2014 Nov 21;20(43):16227-35. doi: 10.3748/wjg.v20.i43.16227.

49.

Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.

Namikawa M, Kakizaki S, Kaira K, Tojima H, Yamazaki Y, Horiguchi N, Sato K, Oriuchi N, Tominaga H, Sunose Y, Nagamori S, Kanai Y, Oyama T, Takeyoshi I, Yamada M.

Hepatol Res. 2015 Sep;45(9):1014-1022. doi: 10.1111/hepr.12431. Epub 2014 Dec 11.

PMID:
25297701
50.

A case of thyroid storm with a markedly elevated level of circulating soluble interleukin-2 receptor complicated by multiple organ failure and disseminated intravascular coagulation syndrome.

Shimoda Y, Satoh T, Takahashi H, Katano-Toki A, Ozawa A, Tomaru T, Horiguchi N, Kaira K, Nishioka M, Shibusawa N, Hashimoto K, Wakino S, Mori M, Yamada M.

Endocr J. 2014;61(7):691-6. Epub 2014 May 20.

Supplemental Content

Loading ...
Support Center